TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
HEALWELL AI ( (TSE:AIDX) ) has shared an update.
HEALWELL AI announced it will release its Fiscal Third Quarter 2025 financial results on November 6, 2025, followed by a conference call and webcast on November 7, 2025. This announcement is significant for stakeholders as it provides insights into the company’s financial health and operational progress, potentially impacting its market positioning and investor confidence.
The most recent analyst rating on (TSE:AIDX) stock is a Hold with a C$1.50 price target. To see the full list of analyst forecasts on HEALWELL AI stock, see the TSE:AIDX Stock Forecast page.
Spark’s Take on TSE:AIDX Stock
According to Spark, TipRanks’ AI Analyst, TSE:AIDX is a Neutral.
HEALWELL AI’s overall stock score is primarily influenced by its strong revenue growth, which is offset by significant profitability and cash flow challenges. The technical analysis provides a stable outlook, but the negative P/E ratio and lack of dividend yield weigh on the valuation.
To see Spark’s full report on TSE:AIDX stock, click here.
More about HEALWELL AI
HEALWELL AI is a healthcare artificial intelligence company focused on preventative care. It aims to improve healthcare and save lives through early disease identification and detection using proprietary technology. The company develops and commercializes advanced clinical decision support systems to help healthcare providers detect rare and chronic diseases, improve practice efficiency, and enhance patient health outcomes. HEALWELL is publicly traded on the Toronto Stock Exchange under the symbol ‘AIDX’ and on the OTC Exchange under the symbol ‘HWAIF’.
Average Trading Volume: 403,903
Technical Sentiment Signal: Buy
Current Market Cap: C$456.2M
For detailed information about AIDX stock, go to TipRanks’ Stock Analysis page.